URZATEM

This brand name is authorized in Nigeria.

Active ingredients

The drug URZATEM contains a combination of these active pharmaceutical ingredients (APIs):

1	Artemether UNII C7D6T3H22J - ARTEMETHER
	Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas.
	Read more about Artemether
2	Lumefantrine UNII F38R0JR742 - LUMEFANTRINE
	Read more about Lumefantrine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-4849	Tablet	URZATEM TABLET 80/480mg TAB 80 mg; 480 mg	URZATEM TABLET 80/480mg B4-4849 URZATEM TABLET 80/480mg Talc Starch Magnesium stearate Active ingredient ARTEMETHER 80MG, LUMEFANTRINE 480MG Over The Counter (OTC) HAVENTIS PHARMACEUTICAL LIMITED, ADESOYE STREET, MENDE, MARYLAND LAGOS LAGOS FRONT PHARMACEUTICAL PLC, XUANCHENG ECONOMIC AND TECHNICAL DEVELOPEMENT ZONE, ANHUI, CHINA., China 2/23/2023 2/22/2028	23/02/2023
B4-4897	Tablet	URZATEM TABLET 20/120MG TAB 20 mg; 120 mg 1 X 12	45 RNW-PP-136063 URZATEM TABLET 20/120MG ARTEMETHER, LUMEFANTRINE Talc Starch Magnesium stearate Active Ingredient Arthemether 20mg/ Lumfantrine 120mg B4-4897 Drugs ALIMENTARY TRACT AND METABOLISM Imported Products 1X12 Over The Counter (OTC) 12/8/2020 HAVENTIS PHARMACEUTICAL LIMITED, ADESOYE STREET, MENDE, MARYLAND LAGOS LAGOS 8083240643 arstrapharmaltd@outlook.com FRONT PHARMACEUTICAL PLC, XUANCHENG ECONOMIC AND TECHNICAL DEVELOPEMENT ZONE, ANHUI, CHINA., China	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF01	Artemether and lumefantrine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-4849, B4-4897